Shandong Buchang Pharmaceuticals Co., Ltd.SSE: 603858

Announcement on Initially Repurchasing Shares through Call Auction

Jun 3, 2026 · Issued by Shandong Buchang Pharmaceuticals Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jun 3, 2026

On 6ix: 6ix.com/news/announcement-on-initially-repurchasing-shares-through-call-auction-56

Announcement on Initially Repurchasing Shares through Call Auction

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Shandong Buchang Pharmaceuticals Co., Ltd. on 6ix

Earlier from Shandong Buchang Pharmaceuticals

Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Limit Concerning RepurchaseJun 2
Announcement on Progress in Proposed Transfer of Equity in a Holding Subsidiary and Waiver of the Right of First RefusalMay 30
Announcement on Providing Guarantee for Holding SubsidiaryMay 29
Announcement on Providing Guarantee for Wholly-owned SubsidiaryMay 27
Announcement on the Change of Business Scope of Wholly-owned SubsidiaryMay 26

Later from Shandong Buchang Pharmaceuticals

Announcement on Change of Drug Production License of Wholly-owned SubsidiaryJun 9
Announcement on Progress in Holding Subsidiary's Proposal to Invest in the Establishment of a External SubsidiaryJun 10
Announcement on Completion of Registration of Change in Business License for Medical Device by the Holding SubsidiaryJun 11
Announcement on Progress in on Proposed Capital Increase in Holding Subsidiary and Change in Name of Holding SubsidiaryJun 19
Announcement on Implementation Result of Shares Repurchase and Share ChangesJun 23

All Shandong Buchang Pharmaceuticals news releases

Follow Shandong Buchang Pharmaceuticals into a list and get an email when it puts out news.

Follow Shandong Buchang Pharmaceuticals